Pain Market Research Reports & Industry Analysis
In considering the IASP definition, it is important to note that not all potentially tissue-damaging stimuli result in pain. Nociception is the activation of the primary afferent nerves with peripheral terminals that respond differently to noxious stimuli. Nociceptors function primarily to sense and transmit pain signals. Nociception may or may not be perceived as pain, depending on a complex interaction within the nociceptive pathways. If nociceptive stimuli are blocked, pain is not perceived. Finally, it is important to distinguish pain, or nociception, from suffering. Suffering is the state of severe distress associated with events that threaten the intactness of the person. Suffering is an emotion. Pain and suffering are not the same phenomenon.
The person who complained of pain in the heart because of the death of a loved one is suffering rather than experiencing pain as it is defined by the IASP. It is clear that three conditions could exist: 1) suffering occurs in the presence of pain,2) suffering occurs when pain is not present, and 3) pain occurs when suffering is not present. For example, the woman awaiting breast biopsy may suffer because of anticipated loss of her breast. After the biopsy, she may have pain without suffering if the biopsy is negative or pain with suffering if the biopsy is positive for malignancy. Interventions aimed at relieving pain and suffering may have some commonalities, but clearly some interventions for suffering will be inadequate for pain just as some interventions for pain are inadequate for suffering.
Pain Industry Research & Market Reports
-
Global Opioid Anesthetics Market Growth 2024-2030
... Anesthetics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Opioid Anesthetics market. Opioid Anesthetics ... Read More
-
Non-opioid Pain Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 – 2032
... a CAGR of 7.3% from 2024 to 2032. This growth can be attributed to the rising incidence of chronic pain conditions and heightened concerns over opioid addiction and its risks. With a growing number of ... Read More
-
Cancer Supportive Care
... by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. Opioids Therapeutic Class, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$11.1 Billion ... Read More
-
Opioid Use Disorder (OUD) Treatment
... naltrexone alleviate the withdrawal process and provide relief from cravings and opioid effects. Other behavioral therapies such as cognitive behavioral therapy and contingency management seek to change undesirable behaviors as well as incentivize recovery. Counseling, ... Read More
-
Cervical Pillows
... at a CAGR of 5.3% over the analysis period 2023-2030. Support Function, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.0 Billion by the end of ... Read More
-
Non-Opioids Analgesics Drugs Market – Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Products (Medical Cannabis, Menthol- Containing, Omega 3 Fatty Acid, Botulinum Toxins, Capsaicin Derived), Therapeutic Applications (Orthopedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2019-2029F
... Pain, Cancer Pain, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2019-2029F Global Non-Opioids Analgesics Drugs Market was valued at USD 723.48 million in 2023 and is anticipated to project ... Read More
-
Chronic Low Back Pain (CLBP) - Global Clinical Trials Review, 2024
... (CLBP) Clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Low Back Pain (CLBP). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Global Menstrual Drugs Market 2024-2028
... on the menstrual drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the ... Read More
-
Ablation Technology Market by Technology (RF, Pulse Field, Microwave, Laser, Electrical, Ultrasound, Cryo), Product (Generator, Electrode, Probe), Application (CV, Cancer, Pain, Ortho, Cosmetics), Enduser (Hospital, ASC) & Region Global Forecasts to 2029
... technology market is projected to reach USD 9.62 billion by 2029 from USD 6.11 billion in 2024, at a CAGR of 9.5% from 2024 to 2029. Increasing risk for targeted diseases, supportive regulatory standards, and ... Read More
-
Global Geriatric Medicines Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Migraine: 68-Market Analysis and Sales Forecast
... including widely used triptans and ergot alkaloids used in abortive treatment amongst others as well as oral preventive therapies such as antidepressants, anticonvulsants, and beta blockers and the newer CGRP-targeting mAbs or gepants across the ... Read More
-
Migraine: Seven-Market Drug Forecast and Market Analysis
... the value of the migraine market in the 7MM in 2023 was $9.2 billion. This market is defined as sales of acute and preventatitve treatments including widely used triptans and ergot alkaloids used in abortive ... Read More
-
Japan Endometriosis Drugs Market By Treatment Type (Pain Medication, Hormone Therapy), By Drug Class (NSAIDs, Oral Contraceptive, Gonadotropin Releasing Hormone, and Others), By Route Of Administration (Oral, Injectable, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
... Retail Pharmacy, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F Japan Endometriosis Drugs Market was valued at USD 59.64 Million in 2024 and is expected to reach USD 84.60 Million by 2030 with a ... Read More
-
Japan Topical Pain Relief Market, By Therapeutic (Non-opioids, Opioids), By Formulation (Cream, Gel, Spray, Patch, Others), By Distribution Channel (Pharmacies & drug stores, E-Commerce, Retail & grocery stores), By Region, Competition, Forecast & Opportunities, 2020-2030F
... Japan Topical Pain Relief Market was valued at USD 250.25 million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.10% through 2030. The Japan Topical Pain ... Read More
-
Pain and Fever Relief Drugs Industry Forecasts - China Focus
... pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing ... Read More
-
Pain and Fever Relief Drugs Markets in China
... continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This ... Read More
-
Pain and Fever Relief Drugs Companies in China
... fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far ... Read More
-
Chronic Pain Market, By Drug Class (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, and Others), By Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia, and Others), By Application (Musculoskeletal, Neuropathy, Oncology, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Chronic pain is defined as any pain lasting for more ... Read More
-
Global Aromatherapy Market Size study, by Product (Consumables, Equipment), by Mode of Delivery (Topical Application, Aerial Diffusion, Direct Inhalation), by End-use (Home Use, Spa & Wellness Centers, Hospitals & Clinics, Yoga & Meditation Centers), by Sales Channel (E-commerce, Offline Stores), by Application (Relaxation, Skin & Hair Care, Pain Management, Cold & Cough, Insomnia, Scar Management, Others) and Regional Forecasts 2023-2032
... Sales Channel (E-commerce, Offline Stores), by Application (Relaxation, Skin & Hair Care, Pain Management, Cold & Cough, Insomnia, Scar Management, Others) and Regional Forecasts 2023-2032 The global aromatherapy market, valued at USD 8.6 billion in ... Read More
-
Global Endometriosis Market Size Study by Type (Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Others), by Treatment (Pain Medication, Hormone Birth Control, Gonadotropin-releasing Hormone (GnRH) Analogues, Aromatase Inhibitors, Others), by Route of Administration (Oral, Parenteral, Others), by End-Users (Hospitals, Homecare, Speciality Centres, Others), by Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) and Regional Forecasts 2022-2032
... Others), by End-Users (Hospitals, Homecare, Speciality Centres, Others), by Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) and Regional Forecasts 2022-2032 The Global Endometriosis Market is valued at approximately USD 1.22 billion in 2023 and ... Read More
-
Japan Cold Pain Therapy Market, By Product (OTC Products, Prescription Products), By Application (Orthopedic Conditions, Post-operative Therapy, Sports Medicine, Post-trauma Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), By Region, Competition, Opportunities, & Forecast, 2020-2030F
... 2020-2030F Japan Cold Pain Therapy Market was valued at USD 140.40 million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.65% through 2030. The Cold Pain ... Read More
-
Electrical Stimulation Devices
... by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Pain Management Application, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$5.4 Billion ... Read More
-
Ulcerative Colitis Therapeutics
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$5.6 Billion by ... Read More
-
Opioid Overdose - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Intrathecal Pumps
... at a CAGR of 5.0% over the analysis period 2023-2030. Morphine, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$115.9 Million by the end of the ... Read More
Research Assistance
